Everything is personalized, which helps ensure your IV therapy feels supportive, comfortable, and appropriate for you
Proven Weight Loss: Clinical studies, including the SURMOUNT-1 trial, have shown that Mounjaro can help people with obesity (without diabetes) lose an average of 15% to over 20% of their body weight
Integration of the gut in human glucose metabolism and its role in diabetes and obesity Centers on the pathophysiology of type 2 diabetes (with focus on glucagon and the gut-derived incretin hormones), obesity, regulation of appetite and food intake and utilization of incretins as therapeutics
J Ethnopharmacol 97:273280 Ohashi A, Yasuda H, Kamiya T, Hara H, Adachi T (2017) CAPE increases the expression of SOD3 through epigenetics in human retinal endothelial cells